Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.3500 (-5.66%) ($23.3500 - $23.3500) on Wed. Jul. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.48% (three month average) | RSI | 46 | Latest Price | $23.3500(-5.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) IWO(41%) ARKG(40%) IWC(40%) | Factors Impacting IOVA price | IOVA will decline at least -3.24% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) TBT(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.24% (StdDev 6.48%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $25.43 | 5 Day Moving Average | $25.07(-6.86%) | 10 Day Moving Average | $25.5(-8.43%) | 20 Day Moving Average | $25.43(-8.18%) | To recent high | -29.3% | To recent low | 44.5% | Market Cap | $3.419b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |